1. Home
  2. ROG vs MESO Comparison

ROG vs MESO Comparison

Compare ROG & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rogers Corporation

ROG

Rogers Corporation

HOLD

Current Price

$130.02

Market Cap

2.6B

Sector

Technology

ML Signal

HOLD

Logo Mesoblast Limited

MESO

Mesoblast Limited

HOLD

Current Price

$15.33

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROG
MESO
Founded
1832
2004
Country
United States
Australia
Employees
N/A
81
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
ROG
MESO
Price
$130.02
$15.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$133.00
N/A
AVG Volume (30 Days)
246.1K
286.3K
Earning Date
04-28-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
$879,091,000.00
N/A
Revenue This Year
$7.64
$629.74
Revenue Next Year
$6.09
$30.65
P/E Ratio
$532.16
N/A
Revenue Growth
7.07
N/A
52 Week Low
$61.17
$12.66
52 Week High
$169.00
$21.50

Technical Indicators

Market Signals
Indicator
ROG
MESO
Relative Strength Index (RSI) 39.00 47.68
Support Level $129.26 $13.82
Resistance Level $144.46 $16.21
Average True Range (ATR) 4.63 0.67
MACD -0.97 -0.05
Stochastic Oscillator 14.29 29.38

Price Performance

Historical Comparison
ROG
MESO

About ROG Rogers Corporation

Rogers Corp designs develop and manufactures engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.

Share on Social Networks: